期刊
ARKIVOC
卷 -, 期 -, 页码 20-47出版社
ARKAT USA INC
DOI: 10.24820/ark.5550190.p011.382
关键词
Atropisomer; medicinal chemistry; regioselective; SEAr; atroposelective catalysis
资金
- NIGMS [R35GM124637]
- National Science Foundation [Che-1664565, Che-1955086]
Atropisomerism, a commonly overlooked type of chirality, plays an important role in modern drug discovery and can be utilized as a design principle in medicinal chemistry. Leveraging Atropisomerism in drug design can help address synthetic challenges and lead to seemingly disparate projects.
Atropisomerism is a type of chirality that is ubiquitous but often overlooked in modern drug discovery. In this Account we discuss studies on leveraging atropisomerism as a design principle in medicinal chemistry, and how this work led to several seemingly disparate projects that began due to synthetic challenges associated with accessing pharmaceutically relevant atropisomers. [GRAPHICS] .
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据